Erratum

View correction statement:

Erratum

This article refers to:

Erratum

It has been brought to our attention that there is an error in Table 4 of the Review article by Phillips EJ and Mallal SA, titled “Pharmacogenetics of drug hypersensitivity” in the 2010 issue of Pharmacogenomics (Pharmacogenomics 11[7], 973–987 [2010]).

The CBZ section of Table 4 originally appeared as:

Table

CBZ
	B*1502 negative	B*1502 negative		Prevalence of ADR = 1 out of 1000
CBZ SJS	100	0	100	Sensitivity = 100%
CBZ tolerant	3000	96900	99900	Specificity = 97%
Total	3100	96900	100000	NNT to prevent one case = 1000
	PPV = 3.1%	NPV = 100%

The corrected CBZ section of Table 4 is:

Table

CBZ
	B*1502 positive	B*1502 negative		Prevalence of ADR = 1 out of 1000
CBZ SJS	100	0	100	Sensitivity = 100%
CBZ tolerant	3000	96900	99900	Specificity = 97%
Total	3100	96900	100000	NNT to prevent one case = 1000
	PPV = 3.1%	NPV = 100%

The information in the HLA positive column has been corrected from B*1502 negative to B*1502 positive.

The editors of Pharmacogenomics would like to sincerely apologize for any inconvenience or confusion this may have caused our readers.